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Introduction. DiGeorge syndrome is a developmental defect commonly caused by a microdeletion on the long arm of chromosome
22 or less frequently by a deletion of the short armof chromosome 10.Case report.We report a case of a gentlemanwithmild dysmor-
phic features who presented with hypocalcaemia-induced seizures and an associated thyroid mass with a background of learning
difficulties and abnormal immune function. Discussion. DiGeorge syndrome was initially described in 1967 by Angelo DiGeorge.
Themajority of cases are due to a novel mutation.The resulting learning difficulties, congenital heart disease, palatal abnormalities,
hypoplasia/aplasia of the parathyroid and thymus glands, and immune deficiency generally lead to diagnosis in childhood. Presen-
tation in adulthood is rare butmust be borne inmindwhen dealingwith cases of hypocalcaemia even in the absence of florid pheno-
typic features. A link with malignant disease has also been reported and should lead to prompt investigation of concerning masses.
1. Introduction
DiGeorge syndrome is a relatively common developmental
defect, due to a microdeletion of chromosome 22q11.2, and
less commonly 10p13. This is associated with developmental
defects, including hypoplasia of the thymus and parathyroid
glands, facial dysmorphism, congenital heart disease, palatal
abnormalities and renal malformations, as well as learning
difficulties. We report a rare case of DiGeorge syndrome
presenting in adulthood as hypocalcaemia-induced seizures
and a thyroid mass.
2. Case Report
A 34-year-old gentleman with mild dysmorphic features
presented to the emergency department with a sudden onset
loss of consciousness which lasted approximately 1 minute,
during which he sustained tonic-clonic movements which
self-terminated. A 1 year history of episodic carpopedal
spasms and upper limb paraesthesia was elicited. A head
computed tomography (CT) scan was normal. A corrected
calcium level was 1.17mmol/L.
His past medical history included a febrile seizure at 2
years of age, with no history suggestive of absence seizures or
myoclonic jerks. He was operated for testicular torsion, acute
appendicitis, a congenital epigastric hernia, a supraumbilical
hernia, and a removal of an accessory digit in the lefthand, the
latter of which was also present in relatives from his paternal
side. His developmental history included gestation at term
with a birth weight of 3.2 kg and a delayed growth spurt. Until
the age of 13 years he had regular physiotherapy for recurrent
chest and sinus infections, with multiple hospital admissions.
At that point he was thoroughly investigated and a diagnosis
of cystic fibrosis was suspected, with equivocal sodium sweat
tests. Heaf tuberculin skin test (Sterneedle test) in 1985, in
spite of previous TB vaccination, was negative. During his
adolescence he also reported incapacitating muscle cramps,
which later resolved. Learning difficulties were attributed to
his frequent absence from school, but the patient was now in
full time employment.
On examination there was mild facial dysmorphism with
a short philtrum. He was haemodynamically stable, with an
early diastolic murmur. Chest was clear. Examination of the
neck revealed a grossly enlarged right thyroid lobe, with
deviation of the trachea to the left.
Thyroid function tests and antithyroid antibodies were
normal. Serum parathyroid hormone levels were low.
Serum calcitonin levels were elevated. Other routine blood
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Figure 1: Axial CT scan with contrast at the level of T2, showing
an enlarged thyroid gland, larger on the left, with tracheal deviation
and inhomogeneous enhancement.
Figure 2: Axial CT scan with contrast at T4, showing retrosternal
extension of the left thyroid lobe, with maximal diameter of 78mm.
investigations, including magnesium levels, were normal. A
CT scan of the neck and thorax showed a grossly enlarged,
inhomogeneous thyroid glandwhichwas extending deep into
the uppermediastinum and associated with enlarged cervical
lymph nodes (Figures 1 and 2). An incidental right-sided
aortic archwas also noted (Figure 3). In view of themalignant
features on CT, a total thyroidectomy and lymphadenectomy
was performed. Histopathology reported the presence of two
separate follicular adenomata and a nodular goitre.
The patient was discharged on calcium supplements,
alpha-calcidol and antiepileptic drugs. The latter were ini-
tiated in view of tonic carpo-pedal spasms, which were
initially considered to be suggestive of partial seizure activity.
A brain magnetic resonance (MR) scan was unremarkable.
No further seizures were reported during the follow-up
periodwith continuation of calcium supplementation and the
antiepileptic treatment was stopped.
Fluorescence in situ hybridisation (FISH) analysis later
confirmed the diagnosis of DiGeorge syndrome with a
deletion on the long arm of chromosome 22-22q11.2 deletion.
3. Discussion
DiGeorge syndrome, which was originally described in 1967
by Di George et al. [1], is associated with microdeletions of
chromosome 22q11.2 and less commonly chromosome 10p13.
Figure 3: Axial CT scan at T5 revealing the presence of an incidental
right-sided thoracic aorta.
It has an estimated prevalence ranging from 1 in 4000 to 1 in
6395 [2, 3]. In view of the variable penetrance, the incidence
is probably much higher. Most cases (93%) have a de novo
deletion, whereas the remaining 7% have inherited the
deletion. Inheritance is in an autosomal dominant manner.
Familial cases have also been described.
The syndrome is associated with failure of development
of the third and fourth branchial pouches [4]. Mølsted et al.
[5] suggested a failure of or aberrant migration of the neural
crest during the fourth week of embryogenesis. The defective
migration of these cells leads to the syndromewhich is associ-
atedwith variable findings that are, as exemplified by our case,
not always clinically pronounced. These include congenital
heart diseases (74%), palatal abnormalities (69%), learning
difficulties (80%) [6], hypoplasia or aplasia of the parathyroid
glands and thymus glands, which cause hypocalcaemia (50%)
and immune deficiency (70%) [7]. Behavioural and psychi-
atricmorbidity is also prevalent, with higher rates of attention
deficit hyperactivity disorder (ADHD), affective disorder,
schizophrenia and anxiety than the normal population, par-
ticularly in adults [8]. In an observational study, 30% of adults
with deletions of chromosome 22q11 experienced a psychotic
disorder, with approximately 25% of subjects satisfying the
diagnostic criteria for schizophrenia [9]. Less frequent find-
ings which have been reported include hearing loss, growth
hormone deficiency, autoimmune disorders, and increased
incidence of unprovoked seizures in the absence of hypocal-
caemia [10]. Typical dysmorphic features for this syndrome
have been described. However these may be subtle, particu-
larly in cases diagnosed in adulthood, in whom these may be
absent. Characteristic dysmorphic features include microg-
nathia, short philtrum with fish-mouth appearance, anti-
amygdaloid slant of the lateral chantus, telecanthuswith short
palpebral fissures, hypertelorism, and low-set ears [11, 12].
Congenital heart defects are the major cause of mortality
in this syndrome and have been reported in 75% of patients
[12]. Findings include tetralogy of Fallot, aortic arch anoma-
lies and ventricular and atrial septal defects.
Associated palatal abnormalities may not be a presenting
feature, although patients with this syndrome often have
unrecognised abnormalities. The commonest abnormality is
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velopharyngeal incompetence. Only about 17% of patients
have no palatal involvement.
Other systems are also involved. Skeletal findings include
polydactyly of the hands, accessory ribs, hemivertebrae, and
craniosynostosis. Renal anomalies, laryngotracheal abnor-
malities, ophthalmological findings and CNS involvement
have been reported. Gastrointestinal anomalies have been
found in association with this syndrome, including umbilical
and diaphragmatic hernias, accessory spleens, oesophageal
and jejunal atresia, and Hirschsprung’s disease.
Immune system involvement is secondary to abnormal
development of the thymus, with subsequent aberrant devel-
opment of T cells [13]. In the majority of patients, this T
cell immunodeficiency is surprisingly milder than expected.
In this latter group, usually classified as “partial” DiGeorge
syndrome, there is a lower number of functional circulating
T cells.There is evidence that in this group of patients further
development of T cells occurs within the first years of life,
with both an increase in production of T cells through home-
ostatic expansion and further immune function development
[14]. Only a few studies investigating the immunological
function of adult DiGeorge patients exist, however these
indicate a trend towards normal T cell counts in adulthood
[15]. Opportunistic infections in adulthood are therefore
rarely reported [16].However, as homeostatic expansion leads
to T cells with shorter telomeres that in turn leads to pre-
mature senescence and lower T cell recombination [17, 18],
the effectiveness of T cell function has been hypothesized to
decline with age. This could explain the lack of a positive
response to the Heaf tuberculin skin test in a previously
immunised patient, as seen in our case. Humoral immune
responses are also affected. These include evidence of IgA
deficiency, impaired responses to vaccines, and reports of
hypogammaglobulinaemia, with specific antibody deficien-
cies being described in over half the DiGeorge subjects in one
study [19–21].
The T cell immunodeficiency is of major significance in
patients with “complete” DiGeorge syndrome and aplasia of
the thymus, where affected patients need immune reconsti-
tution, usually with bone marrow transplantation or thymic
transplants. This is fortunately rare, occurring in less than 1%
of reported cases [22]. The disruption of the thymic function
also predisposes these patients to autoimmune diseases, with
homeostatic expansion showing a tendency for self-reactive
T cells and a decrease in regulatory T cells [23, 24].
A number of reports have also associated DiGeorge
syndrome with an increased risk of malignancy [25]. This
could be accounted for by the patient’s immunodeficiency,
chronic inflammation secondary to recurrent infections,
and deletion of cathecol-O-methyltransferase (COMT) gene
which is usually included in the hemizygous deletion, the
product of which is involved in toxin metabolism. Lympho-
mas, leukaemias, neuroblastomas, hepatoblastomas, Wilm’s
tumour, renal cell carcinoma, and thyroid carcinoma have
all been reported in patients with DiGeorge syndrome. All
were age appropriate, apart from the occurrence of thyroid
carcinoma in a young patient.
Age of presentation depends on the severity and type of
defects associated with the condition. Very early presentation
in the neonatal period is usually due to presentation with car-
diac disease or severe hypocalcaemia. Patients with minimal
facial features, recurrent infections, or mild cardiac disorders
are diagnosed later on in childhood.
4. Conclusion
This is a rare case of DiGeorge syndrome, who presented in
adulthood with hypocalcaemia-induced seizures. Few cases
of adult presentation have been described in the literature
[26, 27].The patient had extensive but nonspecific complaints
throughout his childhood, including delayed development
of immune function, skeletal findings, learning difficulties,
and cardiac abnormalities. Although rare, DiGeorge syn-
drome should be considered in the differential diagnosis of
hypocalcaemia presenting in adulthood, even in the absence
of classical morphological features.The possible link between
DiGeorge syndrome and malignancy must also be borne in
mind when dealing with suspicious mass lesions.
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